NovaBridge Biosciences share price logo

NovaBridge Biosciences

NASDAQ: NBP

$1.38

-0.07

(-4.83%)

as on

NovaBridge Biosciences Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.31
    $1.44
    downward going graph

    5.07%

    Downside

    4.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

NovaBridge Biosciences share price movements today

Previous Close
$1.45
Open
$1.43
Volume
8.2M
Market Cap
$167.7M
Day's Low - High
$1.31 - $1.44

NovaBridge Biosciences Historical Returns

1 Month Return
-26.2 %
3 Month Return
-15.85 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

NovaBridge Biosciences Stock Fundamentals & Key Indicators

Check NovaBridge Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$167.7M

EPS (TTM)

-0.5688

Dividend Yield

0.00%

PE Ratio (TTM)

-2.54

Industry PE ratio

-2.65

PEG Ratio

-0.1951512110341438

Return On Equity TTM

-1.45%

NovaBridge Biosciences Stock Valuation

Track how NovaBridge Biosciences P/E has moved over time to understand its valuation trends.

NovaBridge Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-25.22x)

March 31, 2026

Today (-25.22x)

March 31, 2026

Industry (-2.65x)

March 31, 2026

Highest (-0.77x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -25.22x

NovaBridge Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovaBridge Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$167.7MNA-2.540.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Analyst Recommendation on NovaBridge Biosciences Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for NovaBridge Biosciences. Average target price of $9

Indian Investors' Interest in NovaBridge Biosciences Stock

Search interest for NovaBridge Biosciences Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:27% versus previous 30 day period

NovaBridge Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-30
237
-
71
-
-
-
-
-
-
Gross Profit
-30
237
-
71
-
-
-
-
-
-
Operating Income
-179
-174
-90
-124
-12
-5
-7
-8
-20
-20
EBITDA
-173
-168
-84
-118
-6
-5
-7
-8
-20
-20
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
6
5
5
5
5
-
-
0
0
0
Income Before Tax
-392
-730
-69
-58
-20
-3
-5
-6
-18
-18
Income Tax Expense
-149
-384
-
6
-
-
-
-
-
-
Net Income
-243
-346
20
-33
-20
-3
-5
-6
-18
-18
Net Profit Margin
100.00%
-1687.47%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

NovaBridge Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Total Revenue
11
53
30
1,542
88
-10
4
-
-
Gross Profit
11
53
30
1,542
41
-10
4
-
-
Operating Income
-273
-455
-1,464
155
-2,071
-366
-511
-375
-13
EBITDA
-279
-431
-197
168
-2,057
-356
-344
-373
-13
Interest Expense
0
1
0
0
-
-
0
-
-
Depreciation
1
6
9
12
13
9
3
1
0
Income Before Tax
-290
-416
-1,451
483
-2,332
-973
-1,465
-362
-12
Income Tax Expense
-
1
-
12
0
-5
-1,258
-
-
Net Income
-298
-402
-1,448
470
-2,331
-967
-1,465
-162
-6
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
47.25%
2325.83%
100.00%
0.00%
0.00%

NovaBridge Biosciences Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-346
-346
20
180
-143
-22
-13
-48
-18
-18
Operating Cash Flow
-
-
-
-
-
-
-
13
-16
-16
Investing Cash Flow
-
-
-
-
-
-
-
0
6
6
Financing Cash Flow
-
-
-
-
-
-
-
433
0
0
Change in Cash
-
-
-
-
-
-
-
446
-213
-

NovaBridge Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Net Income
-298
-402
-1,451
470
-2,331
-2,507
-208
-362
-88
Operating Cash Flow
-252
-280
-867
433
-973
-1,102
-72
-384
-20
Investing Cash Flow
-157
9
212
-201
-727
458
-107
-992
104
Financing Cash Flow
758
1,479
152
3,440
593
42
-8
-2
57
Change in Cash
348
1,268
-487
3,565
-1,235
-212
-151
-1,706
142

Mutual Funds that own NovaBridge Biosciences Stock

Check out the Mutual Funds with significant holdings in NovaBridge Biosciences.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.049187%
56753
DFA INVESTMENT DIMENSIONS GROUP INC
0.017364%
20035

Global Institutional Holdings in NovaBridge Biosciences

Funds
Holdings
iShares
0.71%
Michael Rockefeller
0.3%
State Street
0.27%
ALPS
0.13%
Invesco
0.06%

NovaBridge Biosciences News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 04:58 PM

    -

    NovaBridge Biosciences appoints Martin Dewhurst as independent director, enhancing board governance and strategic direction.

Insights on NovaBridge Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 100.0% return, outperforming this stock by 87.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 772.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NBP stock has moved down by -13.8%

About NovaBridge Biosciences

NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.
OrganisationNovaBridge Biosciences
Headquarters2440 Research Boulevard, Rockville, MD, 20850, US
IndustryBiotechnology
CEOSrishti Gupta
E-voting on sharesClick here to vote

Key Management of NovaBridge Biosciences

Name

Title

Ms. Liwei Lin

General Counsel & Board Secretary

Dr. Cong Xu M.D., Ph.D.

Senior VP and Head of R&D Center of Excellence

Dr. Phillip Dennis M.D., Ph.D.

Chief Medical Officer

Dr. Srishti Gupta M.D.

CEO & Director

Mr. Mark Hagler

President & Chief Commercial Officer

Mr. Sean Wuxiong Cao M.B.A., Ph.D.

Chief Business Development Officer & Director

Mr. Tyler Ehler

Senior Director of Investor Relations

Mr. Wei Fu

Executive Chairman

Mr. Ming Lei

Chief Financial Officer

FAQs

What is NovaBridge Biosciences share price today?

NovaBridge Biosciences share price today is $1.38 as on at the close of the market. NovaBridge Biosciences share today touched a day high of $1.44 and a low of $1.31.

What is the 52 week high and 52 week low for NovaBridge Biosciences share?

NovaBridge Biosciences share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . NovaBridge Biosciences stock price today i.e. is closed at $1.38,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NovaBridge Biosciences's market capitalisation today?

NovaBridge Biosciences market capitalisation is $0.00T as on .

How to invest in NovaBridge Biosciences Stock (NBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NovaBridge Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovaBridge Biosciences Shares that will get you 1.0870 shares as per NovaBridge Biosciences share price of $1.38 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy NovaBridge Biosciences Stock (NBP) from India?

Indian investors can start investing in NovaBridge Biosciences (NBP) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in NovaBridge Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on NovaBridge Biosciences share’s latest price of $1.38 as on September 26, 2026 at 8:46 am IST, you will get 7.2464 shares of NovaBridge Biosciences. Learn more about fractional shares .